Janice Vaughn
Family · Bristol, NHNPI 1316247596
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 275 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 25.3% of the total. Among family clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $25.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axsome Therapeutics, Inc.$1K
- Neurocrine Biosciences, Inc.$888
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$632
- Takeda Pharmaceuticals U.S.A., Inc.$479
- Alkermes, Inc.$453
- plus $1K from 16 others
What the payments were for
- Food & beverage$6,87299%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,907 in reported general payments places this provider in the 95th percentile of 713 family providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 33 | $286,640 |
| VraylarCariprazine Hcl | 137 | $205,350 |
| TrintellixVortioxetine Hydrobromide | 56 | $32,963 |
| Invega SustennaPaliperidone Palmitate | 12 | $27,264 |
| AuvelityDextromethorphan Hbr/Bupropion | 23 | $26,922 |
| CaplytaLumateperone Tosylate | 11 | $23,613 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 93 | $4,547 |
| Aripiprazole | 62 | $3,342 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 38 | $3,179 |
| Olanzapine | 93 | $2,778 |
| Bupropion XlBupropion Hcl | 97 | $2,650 |
| Lurasidone Hcl | 16 | $2,491 |
| Quetiapine Fumarate | 149 | $2,268 |
| Vilazodone Hcl | 22 | $2,163 |
| Paliperidone ErPaliperidone | 19 | $1,692 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $888 | $286,64033 claims |
| AbbVieVraylar | $1,745 | $205,350137 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $479 | $32,96356 claims |
| Johnson & JohnsonInvega Sustenna | $105 | $27,26412 claims |
| Axsome Therapeutics, Inc.Auvelity | $1,351 | $26,92223 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $632 | $23,61311 claims |
| Lilly USA, LLCOlanzapine | $64 | $2,77893 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 713 family providers in New Hampshire.
Other family in Bristol
- Tara Delle ChiaieHampton$548K
- Wendy WrightAmherst$447K
- Richard CareyNashua$51K
- Summer BellDerry$16K
- Laura HudsonDover$14K
- Debra KrisonNorth Hampton$13K
- Michelle WhiteBedford$9K
- Brant OliverConcord$9K
- Cassandra CavanaughDover$9K
- Scott SabishConcord$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.